ABSTRACT SUBMISSION GUIDELINES
Submissions must clearly indicate the following:
Format
-
Title – Limit 25 words using sentence case (i.e., capitalize the first word while the remaining words begin in lowercase). Provide a succinct title that should ideally contain a reference to the study design.
-
Authors / Affiliations
-
Abstract Body
-
Length 250 words (not including title, authors and affiliations or keywords) written in single space
-
Tables and figures are not permitted
-
Format – Objectives: / Design and Methods: / Results: / Conclusions:
-
Keywords – maximum of 5
-
Funding Acknowledgement – if required
-
Granting Agency and Number – e.g., Ontario Neurotrauma Foundation 2012-017
Please also note the following submission guidelines:
-
Writing must be concise, clear, and grammatically correct.
-
Technical information pertaining to observations and conclusions cannot be withheld for proprietary reasons. It is not acceptable to state that “results will be discussed”.
-
Special characters should instead be written out (e.g., micromol/L instead of μmol/L).
-
All abbreviations should be defined when first used.
-
If used, references should be given in parentheses without authors or title by provided Index-Medicus-listed Journal abbreviations without punctuation followed by the year, volume number and inclusive page numbers (e.g., Clin Biochem 2002;35:151-169).
-
All presenting authors must register for the conference and pay the registration fees to be selected for the presentation.
-
Five abstracts for oral presentation will be selected.
Please submit abstracts online by March 31, 2023, for consideration.